We’re launching our first clinical trial in the Middle East at Cleveland Clinic Abu Dhabi in partnership with the Department of Health Abu Dhabi!
The UAE-PRIME trial explores how individuals with motor and speech impairment can use thought to control devices & communicate.
🇦🇪 We’re launching our first clinical trial in the Middle East at Cleveland Clinic Abu Dhabi in partnership with the Department of Health Abu Dhabi!
The UAE-PRIME trial explores how individuals with motor and speech impairment can use thought to control devices & communicate. pic.twitter.com/hRzjCObzOk
— Neuralink (@neuralink) May 14, 2025